nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—Captopril—systemic scleroderma	0.151	0.245	CbGbCtD
Pethidine—ALB—Mycophenolate mofetil—systemic scleroderma	0.119	0.193	CbGbCtD
Pethidine—ALB—Prednisone—systemic scleroderma	0.0948	0.154	CbGbCtD
Pethidine—CYP2D6—Captopril—systemic scleroderma	0.0743	0.121	CbGbCtD
Pethidine—CYP2C19—Prednisone—systemic scleroderma	0.0615	0.1	CbGbCtD
Pethidine—ALB—Methotrexate—systemic scleroderma	0.0476	0.0774	CbGbCtD
Pethidine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0372	0.0605	CbGbCtD
Pethidine—CYP3A4—Prednisone—systemic scleroderma	0.0297	0.0484	CbGbCtD
Pethidine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00139	0.00361	CcSEcCtD
Pethidine—Anorexia—Mometasone—systemic scleroderma	0.00139	0.0036	CcSEcCtD
Pethidine—Palpitations—Captopril—systemic scleroderma	0.00139	0.0036	CcSEcCtD
Pethidine—Loss of consciousness—Captopril—systemic scleroderma	0.00138	0.00358	CcSEcCtD
Pethidine—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00137	0.00354	CcSEcCtD
Pethidine—Sweating—Lisinopril—systemic scleroderma	0.00136	0.00354	CcSEcCtD
Pethidine—Urticaria—Pentoxifylline—systemic scleroderma	0.00134	0.00348	CcSEcCtD
Pethidine—Hyperkinesia—Prednisone—systemic scleroderma	0.00132	0.00341	CcSEcCtD
Pethidine—Dry mouth—Captopril—systemic scleroderma	0.00131	0.00339	CcSEcCtD
Pethidine—Bradycardia—Lisinopril—systemic scleroderma	0.0013	0.00337	CcSEcCtD
Pethidine—Euphoric mood—Prednisone—systemic scleroderma	0.0013	0.00336	CcSEcCtD
Pethidine—Confusional state—Captopril—systemic scleroderma	0.00129	0.00335	CcSEcCtD
Pethidine—Anaphylactic shock—Captopril—systemic scleroderma	0.00128	0.00332	CcSEcCtD
Pethidine—Hallucination—Lisinopril—systemic scleroderma	0.00127	0.00329	CcSEcCtD
Pethidine—Decreased appetite—Mometasone—systemic scleroderma	0.00127	0.00329	CcSEcCtD
Pethidine—Shock—Captopril—systemic scleroderma	0.00126	0.00327	CcSEcCtD
Pethidine—Tachycardia—Captopril—systemic scleroderma	0.00125	0.00324	CcSEcCtD
Pethidine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00124	0.00323	CcSEcCtD
Pethidine—Muscle spasms—Leflunomide—systemic scleroderma	0.00124	0.00322	CcSEcCtD
Pethidine—Anorexia—Captopril—systemic scleroderma	0.00122	0.00317	CcSEcCtD
Pethidine—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00122	0.00316	CcSEcCtD
Pethidine—Asthenia—Pentoxifylline—systemic scleroderma	0.00121	0.00314	CcSEcCtD
Pethidine—Hypotension—Captopril—systemic scleroderma	0.0012	0.0031	CcSEcCtD
Pethidine—Pruritus—Pentoxifylline—systemic scleroderma	0.0012	0.0031	CcSEcCtD
Pethidine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00119	0.0031	CcSEcCtD
Pethidine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00119	0.00308	CcSEcCtD
Pethidine—Flushing—Lisinopril—systemic scleroderma	0.00118	0.00307	CcSEcCtD
Pethidine—Vertigo—Leflunomide—systemic scleroderma	0.00116	0.00301	CcSEcCtD
Pethidine—Insomnia—Captopril—systemic scleroderma	0.00116	0.003	CcSEcCtD
Pethidine—Tremor—Mycophenolic acid—systemic scleroderma	0.00116	0.003	CcSEcCtD
Pethidine—Coma—Methotrexate—systemic scleroderma	0.00115	0.00299	CcSEcCtD
Pethidine—Palpitations—Leflunomide—systemic scleroderma	0.00114	0.00296	CcSEcCtD
Pethidine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00295	CcSEcCtD
Pethidine—Somnolence—Captopril—systemic scleroderma	0.00114	0.00295	CcSEcCtD
Pethidine—Agitation—Mycophenolic acid—systemic scleroderma	0.00113	0.00294	CcSEcCtD
Pethidine—Dizziness—Pentoxifylline—systemic scleroderma	0.00112	0.0029	CcSEcCtD
Pethidine—Hypertension—Leflunomide—systemic scleroderma	0.00112	0.0029	CcSEcCtD
Pethidine—Decreased appetite—Captopril—systemic scleroderma	0.00111	0.00289	CcSEcCtD
Pethidine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00289	CcSEcCtD
Pethidine—Erythema—Lisinopril—systemic scleroderma	0.00111	0.00288	CcSEcCtD
Pethidine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00111	0.00287	CcSEcCtD
Pethidine—Syncope—Mycophenolic acid—systemic scleroderma	0.00111	0.00287	CcSEcCtD
Pethidine—Anxiety—Leflunomide—systemic scleroderma	0.0011	0.00285	CcSEcCtD
Pethidine—Constipation—Captopril—systemic scleroderma	0.0011	0.00284	CcSEcCtD
Pethidine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00109	0.00283	CcSEcCtD
Pethidine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00108	0.00281	CcSEcCtD
Pethidine—Affect lability—Prednisone—systemic scleroderma	0.00108	0.0028	CcSEcCtD
Pethidine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00108	0.0028	CcSEcCtD
Pethidine—Dry mouth—Leflunomide—systemic scleroderma	0.00108	0.00279	CcSEcCtD
Pethidine—Vomiting—Pentoxifylline—systemic scleroderma	0.00107	0.00279	CcSEcCtD
Pethidine—Psychotic disorder—Prednisone—systemic scleroderma	0.00107	0.00278	CcSEcCtD
Pethidine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00107	0.00277	CcSEcCtD
Pethidine—Muscle spasms—Lisinopril—systemic scleroderma	0.00107	0.00277	CcSEcCtD
Pethidine—Rash—Pentoxifylline—systemic scleroderma	0.00107	0.00276	CcSEcCtD
Pethidine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00107	0.00276	CcSEcCtD
Pethidine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00106	0.00276	CcSEcCtD
Pethidine—Headache—Pentoxifylline—systemic scleroderma	0.00106	0.00275	CcSEcCtD
Pethidine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00106	0.00274	CcSEcCtD
Pethidine—Feeling abnormal—Captopril—systemic scleroderma	0.00106	0.00274	CcSEcCtD
Pethidine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00105	0.00271	CcSEcCtD
Pethidine—Asthenia—Mometasone—systemic scleroderma	0.00105	0.00271	CcSEcCtD
Pethidine—Irritability—Prednisone—systemic scleroderma	0.00105	0.00271	CcSEcCtD
Pethidine—Hypotension—Azathioprine—systemic scleroderma	0.00104	0.00271	CcSEcCtD
Pethidine—Cardiac arrest—Prednisone—systemic scleroderma	0.00104	0.0027	CcSEcCtD
Pethidine—Tremor—Lisinopril—systemic scleroderma	0.00104	0.0027	CcSEcCtD
Pethidine—Mood swings—Prednisone—systemic scleroderma	0.00104	0.00269	CcSEcCtD
Pethidine—Pruritus—Mometasone—systemic scleroderma	0.00103	0.00268	CcSEcCtD
Pethidine—Tachycardia—Leflunomide—systemic scleroderma	0.00103	0.00267	CcSEcCtD
Pethidine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00103	0.00266	CcSEcCtD
Pethidine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00102	0.00265	CcSEcCtD
Pethidine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00102	0.00263	CcSEcCtD
Pethidine—Oedema—Mycophenolic acid—systemic scleroderma	0.00101	0.00261	CcSEcCtD
Pethidine—Anorexia—Leflunomide—systemic scleroderma	0.00101	0.00261	CcSEcCtD
Pethidine—Nausea—Pentoxifylline—systemic scleroderma	0.001	0.0026	CcSEcCtD
Pethidine—Vertigo—Lisinopril—systemic scleroderma	0.000998	0.00259	CcSEcCtD
Pethidine—Syncope—Lisinopril—systemic scleroderma	0.000996	0.00258	CcSEcCtD
Pethidine—Shock—Mycophenolic acid—systemic scleroderma	0.000991	0.00257	CcSEcCtD
Pethidine—Hypotension—Leflunomide—systemic scleroderma	0.000986	0.00256	CcSEcCtD
Pethidine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000983	0.00255	CcSEcCtD
Pethidine—Palpitations—Lisinopril—systemic scleroderma	0.000982	0.00255	CcSEcCtD
Pethidine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000977	0.00253	CcSEcCtD
Pethidine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000973	0.00252	CcSEcCtD
Pethidine—Visual disturbance—Methotrexate—systemic scleroderma	0.000966	0.00251	CcSEcCtD
Pethidine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00096	0.00249	CcSEcCtD
Pethidine—Insomnia—Leflunomide—systemic scleroderma	0.000955	0.00248	CcSEcCtD
Pethidine—Anxiety—Lisinopril—systemic scleroderma	0.000943	0.00245	CcSEcCtD
Pethidine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000941	0.00244	CcSEcCtD
Pethidine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000936	0.00243	CcSEcCtD
Pethidine—Vomiting—Mometasone—systemic scleroderma	0.000927	0.0024	CcSEcCtD
Pethidine—Dry mouth—Lisinopril—systemic scleroderma	0.000925	0.0024	CcSEcCtD
Pethidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000921	0.00239	CcSEcCtD
Pethidine—Rash—Mometasone—systemic scleroderma	0.000919	0.00238	CcSEcCtD
Pethidine—Asthenia—Captopril—systemic scleroderma	0.000919	0.00238	CcSEcCtD
Pethidine—Dermatitis—Mometasone—systemic scleroderma	0.000918	0.00238	CcSEcCtD
Pethidine—Decreased appetite—Leflunomide—systemic scleroderma	0.000917	0.00238	CcSEcCtD
Pethidine—Confusional state—Lisinopril—systemic scleroderma	0.000914	0.00237	CcSEcCtD
Pethidine—Headache—Mometasone—systemic scleroderma	0.000913	0.00237	CcSEcCtD
Pethidine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000912	0.00237	CcSEcCtD
Pethidine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000911	0.00236	CcSEcCtD
Pethidine—Oedema—Lisinopril—systemic scleroderma	0.000907	0.00235	CcSEcCtD
Pethidine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000907	0.00235	CcSEcCtD
Pethidine—Pruritus—Captopril—systemic scleroderma	0.000906	0.00235	CcSEcCtD
Pethidine—Constipation—Leflunomide—systemic scleroderma	0.000902	0.00234	CcSEcCtD
Pethidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000895	0.00232	CcSEcCtD
Pethidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000895	0.00232	CcSEcCtD
Pethidine—Shock—Lisinopril—systemic scleroderma	0.000892	0.00231	CcSEcCtD
Pethidine—Tachycardia—Lisinopril—systemic scleroderma	0.000885	0.0023	CcSEcCtD
Pethidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000877	0.00227	CcSEcCtD
Pethidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000875	0.00227	CcSEcCtD
Pethidine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000875	0.00227	CcSEcCtD
Pethidine—Irritability—Methotrexate—systemic scleroderma	0.000874	0.00227	CcSEcCtD
Pethidine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000873	0.00226	CcSEcCtD
Pethidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00087	0.00226	CcSEcCtD
Pethidine—Mood swings—Methotrexate—systemic scleroderma	0.000868	0.00225	CcSEcCtD
Pethidine—Nausea—Mometasone—systemic scleroderma	0.000866	0.00225	CcSEcCtD
Pethidine—Anorexia—Lisinopril—systemic scleroderma	0.000864	0.00224	CcSEcCtD
Pethidine—Constipation—Mycophenolic acid—systemic scleroderma	0.000861	0.00223	CcSEcCtD
Pethidine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00223	CcSEcCtD
Pethidine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000856	0.00222	CcSEcCtD
Pethidine—Hypotension—Lisinopril—systemic scleroderma	0.000847	0.0022	CcSEcCtD
Pethidine—Dizziness—Captopril—systemic scleroderma	0.000847	0.0022	CcSEcCtD
Pethidine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000844	0.00219	CcSEcCtD
Pethidine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000841	0.00218	CcSEcCtD
Pethidine—Urticaria—Leflunomide—systemic scleroderma	0.000838	0.00217	CcSEcCtD
Pethidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00083	0.00215	CcSEcCtD
Pethidine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000826	0.00214	CcSEcCtD
Pethidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000823	0.00214	CcSEcCtD
Pethidine—Insomnia—Lisinopril—systemic scleroderma	0.00082	0.00213	CcSEcCtD
Pethidine—Vomiting—Captopril—systemic scleroderma	0.000814	0.00211	CcSEcCtD
Pethidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000811	0.0021	CcSEcCtD
Pethidine—Rash—Captopril—systemic scleroderma	0.000807	0.00209	CcSEcCtD
Pethidine—Dermatitis—Captopril—systemic scleroderma	0.000807	0.00209	CcSEcCtD
Pethidine—Somnolence—Lisinopril—systemic scleroderma	0.000806	0.00209	CcSEcCtD
Pethidine—Headache—Captopril—systemic scleroderma	0.000802	0.00208	CcSEcCtD
Pethidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000801	0.00208	CcSEcCtD
Pethidine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000795	0.00206	CcSEcCtD
Pethidine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000795	0.00206	CcSEcCtD
Pethidine—Decreased appetite—Lisinopril—systemic scleroderma	0.000788	0.00204	CcSEcCtD
Pethidine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000782	0.00203	CcSEcCtD
Pethidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000778	0.00202	CcSEcCtD
Pethidine—Constipation—Lisinopril—systemic scleroderma	0.000775	0.00201	CcSEcCtD
Pethidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00201	CcSEcCtD
Pethidine—Bradycardia—Prednisone—systemic scleroderma	0.000772	0.002	CcSEcCtD
Pethidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000768	0.00199	CcSEcCtD
Pethidine—Nausea—Captopril—systemic scleroderma	0.000761	0.00197	CcSEcCtD
Pethidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000757	0.00196	CcSEcCtD
Pethidine—Asthenia—Leflunomide—systemic scleroderma	0.000757	0.00196	CcSEcCtD
Pethidine—Hallucination—Prednisone—systemic scleroderma	0.000754	0.00196	CcSEcCtD
Pethidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000747	0.00194	CcSEcCtD
Pethidine—Pruritus—Leflunomide—systemic scleroderma	0.000747	0.00194	CcSEcCtD
Pethidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000742	0.00193	CcSEcCtD
Pethidine—Dizziness—Azathioprine—systemic scleroderma	0.000739	0.00192	CcSEcCtD
Pethidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000722	0.00187	CcSEcCtD
Pethidine—Urticaria—Lisinopril—systemic scleroderma	0.00072	0.00187	CcSEcCtD
Pethidine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000719	0.00186	CcSEcCtD
Pethidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000712	0.00185	CcSEcCtD
Pethidine—Vomiting—Azathioprine—systemic scleroderma	0.000711	0.00184	CcSEcCtD
Pethidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00183	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—systemic scleroderma	0.000706	0.00183	CcSEcCtD
Pethidine—Rash—Azathioprine—systemic scleroderma	0.000705	0.00183	CcSEcCtD
Pethidine—Dermatitis—Azathioprine—systemic scleroderma	0.000704	0.00183	CcSEcCtD
Pethidine—Flushing—Prednisone—systemic scleroderma	0.000704	0.00182	CcSEcCtD
Pethidine—Headache—Azathioprine—systemic scleroderma	0.0007	0.00182	CcSEcCtD
Pethidine—Dizziness—Leflunomide—systemic scleroderma	0.000698	0.00181	CcSEcCtD
Pethidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000691	0.00179	CcSEcCtD
Pethidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000679	0.00176	CcSEcCtD
Pethidine—Sweating—Methotrexate—systemic scleroderma	0.000677	0.00175	CcSEcCtD
Pethidine—Vomiting—Leflunomide—systemic scleroderma	0.000671	0.00174	CcSEcCtD
Pethidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000668	0.00173	CcSEcCtD
Pethidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000666	0.00173	CcSEcCtD
Pethidine—Rash—Leflunomide—systemic scleroderma	0.000665	0.00173	CcSEcCtD
Pethidine—Dermatitis—Leflunomide—systemic scleroderma	0.000665	0.00172	CcSEcCtD
Pethidine—Nausea—Azathioprine—systemic scleroderma	0.000664	0.00172	CcSEcCtD
Pethidine—Headache—Leflunomide—systemic scleroderma	0.000661	0.00171	CcSEcCtD
Pethidine—Erythema—Prednisone—systemic scleroderma	0.00066	0.00171	CcSEcCtD
Pethidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000655	0.0017	CcSEcCtD
Pethidine—Asthenia—Lisinopril—systemic scleroderma	0.000651	0.00169	CcSEcCtD
Pethidine—Pruritus—Lisinopril—systemic scleroderma	0.000642	0.00166	CcSEcCtD
Pethidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00064	0.00166	CcSEcCtD
Pethidine—Rash—Mycophenolic acid—systemic scleroderma	0.000635	0.00165	CcSEcCtD
Pethidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000634	0.00164	CcSEcCtD
Pethidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000631	0.00164	CcSEcCtD
Pethidine—Headache—Mycophenolic acid—systemic scleroderma	0.000631	0.00164	CcSEcCtD
Pethidine—Nausea—Leflunomide—systemic scleroderma	0.000627	0.00163	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—systemic scleroderma	0.000611	0.00158	CcSEcCtD
Pethidine—Agitation—Prednisone—systemic scleroderma	0.000606	0.00157	CcSEcCtD
Pethidine—Dizziness—Lisinopril—systemic scleroderma	0.0006	0.00156	CcSEcCtD
Pethidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000598	0.00155	CcSEcCtD
Pethidine—Vertigo—Prednisone—systemic scleroderma	0.000593	0.00154	CcSEcCtD
Pethidine—Syncope—Prednisone—systemic scleroderma	0.000592	0.00153	CcSEcCtD
Pethidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00152	CcSEcCtD
Pethidine—Loss of consciousness—Prednisone—systemic scleroderma	0.00058	0.0015	CcSEcCtD
Pethidine—Vomiting—Lisinopril—systemic scleroderma	0.000577	0.0015	CcSEcCtD
Pethidine—Rash—Lisinopril—systemic scleroderma	0.000572	0.00148	CcSEcCtD
Pethidine—Convulsion—Prednisone—systemic scleroderma	0.000572	0.00148	CcSEcCtD
Pethidine—Dermatitis—Lisinopril—systemic scleroderma	0.000571	0.00148	CcSEcCtD
Pethidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00057	0.00148	CcSEcCtD
Pethidine—Hypertension—Prednisone—systemic scleroderma	0.00057	0.00148	CcSEcCtD
Pethidine—Headache—Lisinopril—systemic scleroderma	0.000568	0.00147	CcSEcCtD
Pethidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00146	CcSEcCtD
Pethidine—Anxiety—Prednisone—systemic scleroderma	0.00056	0.00145	CcSEcCtD
Pethidine—Erythema—Methotrexate—systemic scleroderma	0.000552	0.00143	CcSEcCtD
Pethidine—Nausea—Lisinopril—systemic scleroderma	0.000539	0.0014	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000539	0.0014	CcSEcCtD
Pethidine—Oedema—Prednisone—systemic scleroderma	0.000539	0.0014	CcSEcCtD
Pethidine—Shock—Prednisone—systemic scleroderma	0.00053	0.00137	CcSEcCtD
Pethidine—Tachycardia—Prednisone—systemic scleroderma	0.000526	0.00136	CcSEcCtD
Pethidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000525	0.00136	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000521	0.00135	CcSEcCtD
Pethidine—Anorexia—Prednisone—systemic scleroderma	0.000513	0.00133	CcSEcCtD
Pethidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000505	0.00131	CcSEcCtD
Pethidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000501	0.0013	CcSEcCtD
Pethidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000501	0.0013	CcSEcCtD
Pethidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00129	CcSEcCtD
Pethidine—Vertigo—Methotrexate—systemic scleroderma	0.000496	0.00129	CcSEcCtD
Pethidine—Insomnia—Prednisone—systemic scleroderma	0.000487	0.00126	CcSEcCtD
Pethidine—Convulsion—Methotrexate—systemic scleroderma	0.000478	0.00124	CcSEcCtD
Pethidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00122	CcSEcCtD
Pethidine—Decreased appetite—Prednisone—systemic scleroderma	0.000468	0.00121	CcSEcCtD
Pethidine—Constipation—Prednisone—systemic scleroderma	0.000461	0.00119	CcSEcCtD
Pethidine—Confusional state—Methotrexate—systemic scleroderma	0.000454	0.00118	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00045	0.00117	CcSEcCtD
Pethidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000444	0.00115	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000435	0.00113	CcSEcCtD
Pethidine—Anorexia—Methotrexate—systemic scleroderma	0.000429	0.00111	CcSEcCtD
Pethidine—Urticaria—Prednisone—systemic scleroderma	0.000428	0.00111	CcSEcCtD
Pethidine—Hypotension—Methotrexate—systemic scleroderma	0.000421	0.00109	CcSEcCtD
Pethidine—Insomnia—Methotrexate—systemic scleroderma	0.000407	0.00106	CcSEcCtD
Pethidine—Somnolence—Methotrexate—systemic scleroderma	0.0004	0.00104	CcSEcCtD
Pethidine—Hypersensitivity—Prednisone—systemic scleroderma	0.000397	0.00103	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—systemic scleroderma	0.000391	0.00101	CcSEcCtD
Pethidine—Asthenia—Prednisone—systemic scleroderma	0.000386	0.001	CcSEcCtD
Pethidine—Pruritus—Prednisone—systemic scleroderma	0.000381	0.000988	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000371	0.000962	CcSEcCtD
Pethidine—Urticaria—Methotrexate—systemic scleroderma	0.000358	0.000927	CcSEcCtD
Pethidine—Dizziness—Prednisone—systemic scleroderma	0.000356	0.000924	CcSEcCtD
Pethidine—Vomiting—Prednisone—systemic scleroderma	0.000342	0.000888	CcSEcCtD
Pethidine—Rash—Prednisone—systemic scleroderma	0.00034	0.000881	CcSEcCtD
Pethidine—Dermatitis—Prednisone—systemic scleroderma	0.000339	0.00088	CcSEcCtD
Pethidine—Headache—Prednisone—systemic scleroderma	0.000337	0.000875	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000332	0.00086	CcSEcCtD
Pethidine—Asthenia—Methotrexate—systemic scleroderma	0.000323	0.000838	CcSEcCtD
Pethidine—Nausea—Prednisone—systemic scleroderma	0.00032	0.00083	CcSEcCtD
Pethidine—Pruritus—Methotrexate—systemic scleroderma	0.000318	0.000826	CcSEcCtD
Pethidine—Dizziness—Methotrexate—systemic scleroderma	0.000298	0.000772	CcSEcCtD
Pethidine—Vomiting—Methotrexate—systemic scleroderma	0.000286	0.000742	CcSEcCtD
Pethidine—Rash—Methotrexate—systemic scleroderma	0.000284	0.000736	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—systemic scleroderma	0.000284	0.000735	CcSEcCtD
Pethidine—Headache—Methotrexate—systemic scleroderma	0.000282	0.000731	CcSEcCtD
Pethidine—Nausea—Methotrexate—systemic scleroderma	0.000267	0.000693	CcSEcCtD
